Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
RACE IT
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
- NCT03529890 ↗
- Unknown
- Technical University of Munich
- Focused
We haven't built an HCP commentary report on RACE IT (nivolumab plus radiation therapy in locally advanced urothelial carcinoma of the bladder) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on RACE IT so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 6 |
The trial
ClinicalTrials.gov- Official title
- A Prospective, Single Arm, Multicenter, Phase II-Trial to Assess Safety and Efficacy of Preoperative RAdiation Therapy Before Radical CystEctomy Combined With ImmunoTherapy in Locally Advanced Urothelial Carcinoma of the Bladder
- Phase
- Phase 2
- Status
- Unknown
- Conditions
- Urinary Bladder Cancer
- Interventions
- Nivolumab; Radiation therapy of the pelvis; Radical cystectomy with standardized pelvic lymphadenectomy
- Arms
- Radio-Immunotherapy before cystectomy · Experimental
- Enrollment
- 33 (estimated)
- Primary outcomes
- Rate of patients with completed Treatment
- Sponsor
- Technical University of Munich with Bristol-Myers Squibb
- Start
- Feb 4, 2019
- Primary completion
- Apr 14, 2022
- Results posted
- No
- Registry record
- NCT03529890 · updated Oct 20, 2022
Publications
linked from the registry- Schmid SC, Koll FJ, Rodel C, Maisch P, Sauter A, Beckert F, Seitz A, Kubler H, Flentje M, Chun F, Combs SE, Schiller K, Gschwend JE, Retz M. Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT). BMC Cancer. 2020 Jan 3;20(1):8. doi: 10.1186/s12885-019-6503-6. PubMed 31900121